Brought to you by 
Boston Scientific acquires the remainder of Rubicon Medical
06 May 2005
Executive Summary
Boston Scientific has exercised its option under a 2003 agreement to acquire the Rubicon Medical (interventional vascular medical devices) shares held by its principal stockholders (chairman David Berger and president and CEO Richard Linder), giving it a 53.6% stake in the company. BS has also agreed to purchase any other remaining outstanding shares; altogether it will pay $71.7mm in cash, with the potential of another $83.7mm in milestone-based earn-outs.
Deal Industry
- Medical Devices
-
Medical Devices
- Surgical Equipment & Devices
Deal Status
- Final
Deal Type
-
Acquisition
- Includes Contract
- Includes Earnout
- Partial Acquisition
- Payment Includes Cash
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Related Companies
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Boston Scientific acquires the remainder of Rubicon Medical
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice